CD4+ T Cell Responses in the Immune Control Against Latent Infection by Epstein-Barr Virus
Journal:
Current Molecular Medicine
Volume:
3
Page:
341-347
Author(s):
Casper Paludan and Christian Munz
Radioprotective Gene Therapy
Journal:
Current Gene Therapy
Volume:
3
Page:
183-195
Author(s):
J. S. Greenberger, M. W. Epperly, J. Gretton, M. Jefferson, S. Nie, M. Bernarding, V. Kagan and H. L. Guo
Neuropeptide Y and Cancer Anorexia
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
3
Page:
127-139
Author(s):
W. T. Chance, A. Balasubramaniam and S. Sheriff
Bone Marrow Reconstitution as a Relevant Model of Genetically Programmed Leukemia
Journal:
Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume:
1
Page:
83-97
Author(s):
A. Dolnikov, S. Shen, T. Passioura and G. Symonds
Preface
Journal:
Current Drug Targets - Infectious Disorders
Volume:
3
Page:
ii-ii
Author(s):
Robert C. Goldman
Targeted Inhibition of Angiogenic Factors in AIDS-related Disorders
Journal:
Current Drug Targets - Infectious Disorders
Volume:
3
Page:
115-128
Author(s):
Yoshiyasu Aoki and Giovanna Tosato
Viral Latent Proteins as Targets for Kaposis Sarcoma and Kaposis Sarcoma-associated Herpesvirus (KSHV / HHV-8) Induced Lymphoma
Journal:
Current Drug Targets - Infectious Disorders
Volume:
3
Page:
129-135
Author(s):
Michelle R. Staudt and Dirk P. Dittmer
Current Perspectives on Cytokines for Anti-retroviral Therapy in AIDS Related B-cell Lymphomas
Journal:
Current Drug Targets - Infectious Disorders
Volume:
3
Page:
137-149
Author(s):
V. Sharma
Particle-based Vaccines for HIV-1 Infection
Journal:
Current Drug Targets - Infectious Disorders
Volume:
3
Page:
151-169
Author(s):
Kelly R. Young and Ted M. Ross
Immune Therapy for Infectious Diseases at the Dawn of the 21st Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
945-968
Author(s):
U. K. Buchwald and L. Pirofski